TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 25 filers reported holding TSCAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,188,493 | +2.4% | 1,245,505 | 0.0% | 0.39% | +38.9% |
Q2 2023 | $3,113,763 | +19.0% | 1,245,505 | 0.0% | 0.28% | +17.2% |
Q1 2023 | $2,615,561 | +35.5% | 1,245,505 | 0.0% | 0.24% | +34.3% |
Q4 2022 | $1,930,533 | -49.2% | 1,245,505 | 0.0% | 0.18% | -33.1% |
Q3 2022 | $3,799,000 | -3.0% | 1,245,505 | 0.0% | 0.27% | +5.1% |
Q2 2022 | $3,917,000 | +12.3% | 1,245,505 | 0.0% | 0.25% | +110.8% |
Q1 2022 | $3,487,000 | -37.8% | 1,245,505 | 0.0% | 0.12% | -16.7% |
Q4 2021 | $5,605,000 | – | 1,245,505 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 630,000 | $1,323,000 | 30.82% |
Deer Management Co. LLC | 1,245,505 | $2,615,561 | 0.24% |
Simplify Asset Management Inc. | 546,916 | $1,148,524 | 0.16% |
Alphabet Inc. | 1,077,080 | $2,261,868 | 0.12% |
Newtyn Management, LLC | 236,800 | $497,280 | 0.10% |
DC Investments Management, LLC | 35,563 | $74,682 | 0.09% |
Privium Fund Management (UK) Ltd | 15,825 | $40,987 | 0.03% |
Baker Brothers Advisors | 2,784,792 | $5,848,063 | 0.03% |
Tekla Capital Management LLC | 200,000 | $420,000 | 0.02% |
NewEdge Wealth, LLC | 91,463 | $192,072 | 0.01% |